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Background: Surveys have indicated that 62 % of preschool-age Indian children suffer from sub-clinical vitamin A
deficiency (VAD), with a threefold higher prevalence of severe forms of VAD among children from schedule castes (SC)
or schedule tribes (ST). The objective of this analysis is to assess whether India’s national vitamin A supplementation
(VAS) programme is reaching the districts with higher concentration of SC/ST children in the seven states with the
largest burden of under-five mortality (74 % of India’s under-five deaths).
Methods: Disaggregated analyses of trends in and outcome VAS coverage and full VAS coverage were conducted
between 2006 and 2011 by state and SC/ST concentration quintile using three data sources—India’s national VAS
programme, Office of the Registrar General and Census Commissioner, and District-Level Household Survey—to compute
exposure (SC and/or ST concentration) and outcome (VAS coverage and full VAS coverage) were conducted.
Results: Between 2006 and 2011, all SC/ST concentration quintiles reported significant increases in full VAS coverage
(two doses/child/year). The mean full VAS coverage over the 6-year period was positively correlated with the SC/ST
concentration quintile: the district quintile with the highest concentration of SC/ST households reported the highest full
VAS coverage (62.5 %), while the district quintile with the lowest concentration of SC/ST households reported the lowest
coverage (47.9 %). The estimated number of children not fully covered by the VAS programme decreased by 39.0 %
among children from SC/ST households and by 51.7 % among children from non-SC/ST households. The mean
annual number of SC/ST children not fully covered was similar across SC/ST concentration quintiles (1.1 to
1.3 million).
Conclusions: Indian states have achieved significant progress in expanding the coverage of the VAS programme.
However, a large proportion of children are not benefitting from this child survival intervention, particularly among
SC/ST children. These children are potentially among the most vulnerable to VAD and its consequences. India’s
national VAS programme needs to be strengthened in sub-district-level units (i.e. blocks and villages) with higher
concentrations of SC/ST children, with particular emphasis on SC children.Background
Several population-based intervention trials have assessed
the contribution of vitamin A deficiency (VAD) to child
mortality [1–8]. Independent meta-analyses of these trials
have indicated that in areas where VAD is prevalent, child
mortality is reduced by 23–34 % following vitamin A in-
terventions [9–12]. This significant improvement in child
survival has been largely attributed to a reduction in* Correspondence: vaguayo@unicef.org
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article, unless otherwise stated.mortality from measles, severe diarrhoea, dysentery,
and possibly falciparum malaria [7, 13–15]. A recent
Cochrane review has concluded that vitamin A supple-
mentation (VAS) should be given to all children at risk
of deficiency, particularly in low and middle income
countries [16, 17]. In light of this compelling evidence,
WHO recommends that in settings where VAD is a
public health problem, children 6–59 months old be
provided vitamin A supplements to reduce child mor-
bidity and mortality [18].
In India, VAD has long been recognized as a public
health problem [19–21]. Surveys carried out betweencle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
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had sub-clinical VAD (serum retinol < 20 μg/dl). These
surveys indicated that the prevalence of more severe
forms of VAD was three times higher among children
from schedule caste (SC) or schedule tribe (ST)
households [22, 23]. Furthermore, India’s 2006 National
Family Health Survey indicated that the proportion of
SC/ST children 6–59 months who had received vitamin
A supplements in the 6 months preceding the survey
was a mere 17 % [24].
Since 2006, the Government of India and India’s State
Governments have made a concerted effort to increase
the coverage of the VAS programme by strengthening
the implementation of bi-annual VAS rounds as part of
the national VAS programme, managed by the Ministry
of Health and Family Welfare. The programme aims at
delivering preventive VAS to children 6–59 months old.
For programmatic convenience, the first VAS dose
(100,000 IU) is administered with the measles vaccin-
ation at ~9 months, while the subsequent eight doses
(200,000 IU each) are administered every 6 months up
to the age of 59 months using bi-annual VAS rounds as
the main delivery platform [25]. The delivery of vitamin
A supplements is ensured by the Auxiliary Nurse
Midwife (ANM) of the Health Department, supported
by the Accredited Social Health Activist (ASHA), the
frontline worker of the National Rural Health Mission
(NRHM), and the Anganwadi Worker, the frontline
worker of Integrated Child Development Services (ICDS)
programme, India’s flagship programmes for child health,
nutrition and development.
In 2006, the states of Bihar, Chhattisgarh, Jharkhand,
Madhya Pradesh, Odisha, Rajasthan and Uttar Pra-
desh—with 52 % of India’s under-five population (i.e.
59.4 million)—were home to 74 % of the under-five
deaths in India, with a combined under-five mortality
rate of 84 deaths for every 1000 live births (63 in India)
[24, 26, 27]. Furthermore, 32.9 % of the combined popu-
lation in these seven states survived below a minimum
standard of living, with poverty levels as high as 47.3 %
in the population quintile with the highest proportion
of SC/ST households [28]. The objective of this analysis
is to assess whether India’s national VAS programme is
reaching the districts with a higher concentration of
children who belong to SC/ST households in the seven
states of India with the largest burden of under-five
mortality.
Methods
We used the latest publicly available data by the Office
of the Registrar General and Census Commissioner of
India to determine the population size, population com-
position (including the proportion of SC/ST households),
and the number of children 6–59 months (SC, ST, andnon-SC/ST) in each of the seven states and 255 districts
included in our analysis [29].
Data collection and collation procedures took into ac-
count the number of children 6–11 months old who re-
ceived VAS through the routine immunization programme
(measles vaccination at ~9 months) and the number of
children 12–59 months old who received VAS through the
bi-annual rounds. The number of children 6–59 months
old who benefitted from the VAS programme in each dis-
trict was determined using standardized bottom-up data
collection and collation approach with data flowing up
from the VAS supplementation sites in the village to the
block, from the block to the district, and from the district
to the state in each given calendar semester (semester 1:
Jan 1–June 30; semester 2: Jul 1–Dec 31).
Following international recommendations,VAS coverage
was defined as the proportion of eligible children who
received at least one VAS dose in a given calendar year
while full VAS coverage was defined as the proportion of
eligible children who received two VAS doses in a given
calendar year. For any given district and calendar year,
VAS coverage was computed as that of the semester with
the highest VAS coverage whereas full VAS coverage was
computed as that of the semester with the lowest VAS
coverage, thus assuming that all children who benefitted
from the VAS programme in the semester with the lowest
VAS coverage also did in the semester with the highest
VAS coverage [30].
STATA12 (StataCorp. 2009; Stata: Release 12. Statistical
Software. College Station, TX: StataCorp LP) was used for
all data analyses. Ethical approval was not sought as we
analyse anonymous data that cannot be linked to individ-
ual children, caregivers, or household identity.
Results
The coverage and full coverage of the VAS programme
was analysed by SC/ST concentration quintile, dividing
the 255 districts into five quintiles (~51 districts per quin-
tile): the lowest quintile comprising the 20 % districts with
the lowest concentration of SC/ST households at one end
and the highest quintile comprising the 20 % districts with
the highest concentration of SC/ST households at the
other end (Table 1).
In 2006, the highest SC/ST quintile reported the highest
full VAS coverage (52.6 %) while the two lower SC/ST
quintiles reported the lowest full VAS coverage (~37.0 %).
Between 2006 and 2011, the full VAS coverage increased
in all SC/ST quintiles. This increase was inversely corre-
lated with the SC/ST concentration quintile: highest
(42.5 percentage points) in the lowest SC/ST quintile and
lowest (8.6 percentage points) in the highest SC/ST quin-
tile (Table 1). However, the mean full VAS coverage over
the 6-year period (2006–2011) was positively correlated
with the SC/ST concentration quintile: highest (62.5 %) in
Table 1 Vitamin A supplementation coverage (at least one
dose/child/year) and full VAS coverage (two doses/child/year)
by SC/ST concentration quintile, India 2006–2011
SC/ST concentration quintile
Year Lowest Lower Middle Higher Highest
VAS coverage 2006 45.9 50.5 63.9 69.7 70.4
2007 71.6 74.6 74.4 83.6 86.4
2008 84.2 85.7 93.6 95.6 97.4
2009 93.0 96.3 98.1 94.7 96.8
2010 85.8 78.6 92.0 93.6 97.4
2011 95.1 96.9 90.1 89.2 88.1
2006–11 79.3 80.4 85.2 87.7 89.4
Full VAS coverage 2006 37.2 37.0 47.4 49.3 52.6
2007 10.5 40.8 44.7 57.5 56.1
2008 69.1 55.1 60.8 53.1 64.6
2009 84.5 85.1 77.7 66.8 65.4
2010 6.1 34.0 43.4 65.6 75.8
2011 79.7 70.3 65.4 60.0 61.2
2006–11 47.9 53.7 56.5 58.6 62.5
Note: Coverage figures are indicated as percentages
Table 2 Vitamin A supplementation coverage (at least one
dose/child/year) and full VAS coverage (two doses/child/year)
by ST concentration quintile, India 2006–2011
ST concentration quintile
Year Lowest Lower Middle Higher Highest
VAS coverage 2006 26.5 55.9 77.3 71.5 70.0
2007 35.1 84.5 90.6 92.1 90.2
2008 61.7 96.3 97.0 103.7 99.1
2009 86.9 101.5 93.8 98.7 98.4
2010 61.0 93.9 95.8 99.0 98.6
2011 81.9 99.7 100.4 93.5 84.9
2006–11 58.6 88.7 92.5 93.0 90.2
Full VAS coverage 2006 9.5 47.3 60.8 58.7 48.6
2007 23.2 16.3 39.9 67.3 62.6
2008 32.1 76.7 68.7 71.6 55.3
2009 75.5 93.1 64.1 74.9 73.1
2010 0.0 13.1 46.1 81.0 85.1
2011 48.2 84.9 69.9 72.6 62.5
2006–11 31.3 55.3 58.2 70.9 64.5
Note: Coverage figures are indicated as percentages
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est SC/ST quintile.
Additionally, we analysed the VAS coverage and full
VAS coverage by ST concentration by dividing the 255
districts into five quintiles: the lowest quintile comprising
the 20 % districts with the lowest concentration of ST
households and the highest quintile comprising the 20 %
districts with the highest concentration of ST households
(Table 2). In 2006, the lowest ST quintile reported the
lowest full VAS coverage (9.5 %) while the remaining ST
quintiles reported full VAS coverage ranging between
47.3 % and 60.8 %. Between 2006 and 2011, the full VAS
coverage increased in all ST quintiles. The highest in-
crease (≥37.6 percentage points) was observed in the two
lowest ST quintiles. However, the mean full VAS coverage
over the 6-year period (2006–2011) was lowest (31.3 %) in
the lowest ST quintile while it was highest (>64.5 %) in
the two highest ST quintiles (Table 2; Fig. 1).
The analysis of the VAS coverage and full VAS
coverage by SC concentration followed the same ap-
proach but revealed a different pattern. In 2006, the
quintile with the lowest concentration of SC house-
holds reported the highest full VAS coverage (52.0 %).
Between 2006 and 2011, the full VAS coverage in-
creased in all quintiles. The lowest increase (3.4 per-
centage points) was observed in the highest SC
quintile. Importantly, the mean full VAS coverage over
the 6-year period was negatively correlated with the
SC concentration: highest (64.9 %) in the lowest SC
quintile and lowest (49.3 %) in the highest SC quintile
(Table 3; Fig. 1).The estimated number of non-fully covered children
decreased from 31.4 million in 2006 to 16.1 million in
2011 (49 % decrease). Over the 6-year period, the mean
number of children who were not fully covered by the
VAS programme annually was highest (8.0 million) in
the lowest SC/ST quintile and lowest (2.3 million) in
the highest SC/ST quintile (Table 4). The number of
non-fully covered SC/ST children in each given year
was estimated by combining the population of children
6–59 months old in the district, the proportion of chil-
dren from SC/ST households in the district, and the full
coverage of the VAS programme in the district. The es-
timated number of children from SC/ST households
who were not fully covered decreased by 39.0 % (from
7.6 million in 2006 to 4.6 million in 2011), while the
number of children from non-SC/ST households who
were not fully covered by the VAS programme de-
creased by 51.7 % (from 23.8 million in 2006 to 11.5
million in 2011). The mean number of non-fully cov-
ered SC/ST children annually between 2006 and 2011
was similar across the five SC/ST quintiles, ranging be-
tween 1.1 and 1.3 million children (Table 5).
Discussion
Between 2006 and 2011, India’s national VAS programme
experienced a significant expansion in the seven states
with the highest burden of child mortality. The increase in
full VAS coverage was observed in all SC/ST quintiles. Im-
portantly, the 2006–11 mean full VAS coverage was high-
est in the district quintiles with the highest concentration
of SC/ST households. A recent review indicates that the
Fig. 1 Mean annual vitamin A supplementation coverage (two doses/child/year) by SC/ST district concentration quintile. India, 2006–2011.
Note: Coverage figures are indicated as percentages
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and Odisha—two of the seven states included in our ana-
lysis—have been: strong leadership by the state govern-
ment, close coordination between the departments of
Health and Family Welfare and Women and Child
Development, effective district-level planning prior toTable 3 Vitamin A supplementation coverage (at least one
dose/child/year) and full VAS coverage (two doses/child/year)
by SC concentration quintile, India 2006–2011
SC concentration quintile
Year Lowest Lower Middle Higher Highest
VAS coverage 2006 67.7 63.2 53.9 53.8 61.4
2007 94.5 83.7 73.1 69.5 69.7
2008 101.2 96.6 81.5 87.3 89.9
2009 102.4 94.6 91.4 95.9 94.6
2010 99.4 95.6 86.0 79.2 86.8
2011 86.3 93.9 94.9 93.1 91.3
2006–11 91.9 88.0 80.1 79.7 82.2
Full VAS coverage 2006 52.0 49.0 40.5 34.8 47.0
2007 56.2 28.7 42.8 44.5 37.3
2008 63.9 73.9 47.9 51.5 65.4
2009 77.1 78.6 78.2 83.3 62.6
2010 73.1 38.7 44.8 34.3 33.9
2011 67.6 74.0 74.1 70.6 50.4
2006–11 64.9 57.2 54.8 53.1 49.3
Note: Coverage figures are indicated as percentageseach biannual VAS round, a stable procurement and
distribution mechanism, appropriate training and
supervision of staff, and intensive social mobilization
and communication [31].
Besides documenting the significant expansion of the
VAS programme in India’s seven high burden states, our
analysis highlights substantial differences in full VAS
coverage between districts with a high concentration of
SC households and districts with a high concentration of
ST households. The 6-year period mean full VAS cover-
age was highest in the district quintiles with the highest
concentration of ST households but was lowest in the
district quintiles with the highest concentration of SC
households. This is potentially the result of geographic
targeting/emphasis by the VAS programme as ST house-
holds tend to cluster in the same geographic area due to
their ancestral link to the land where they live. SC
households, on the contrary, tend to be geographically
mixed with non-SC households and therefore are less
likely to benefit from geographical targeting by public
health programmes.
Despite impressive increases in full VAS coverage—in-
cluding in districts with a high concentration of socially
disadvantaged households—a large a proportion of chil-
dren are not fully covered, particularly among SC and
ST children, who are potentially among the most vulner-
able to VAD and its consequences. Furthermore, as full
VAS coverage increases across all SC/ST concentration
quintiles, the SC and ST children who are not covered
Table 4 Estimated number of children 6–59 months old not covered (at least one dose/child/year) and not fully covered
(two doses/child/year) by SC/ST concentration quintile. Vitamin A supplementation (VAS) programme, India 2006–2011
All children by SC/ST concentration quintile
Year Lowest Lower Middle Higher Highest All
VAS coverage 2006 8,442,301 7,072,482 4,077,309 2,883,883 1,708,795 24,184,770
2007 4,084,300 4,728,549 3,064,163 1,875,644 816,136 14,568,792
2008 2,333,348 2,592,873 1,120,340 763,628 230,042 7,040,231
2009 1,083,499 999,222 532,191 677,110 301,656 3,593,678
2010 2,284,914 3,269,948 1,260,174 787,566 312,240 7,914,842
2011 614,275 1,044,155 1,479,768 1,095,910 815,157 5,049,265
2006–11 3,140,440 3,284,538 1,922,324 1,347,290 697,338 10,391,930
Full VAS coverage 2006 9,624,633 8,885,007 5,690,288 4,492,419 2,725,837 31,418,184
2007 14,028,919 8,727,647 5,994,887 4,158,163 2,730,845 35,640,461
2008 4,639,824 6,162,087 3,992,398 3,844,499 2,137,010 20,775,818
2009 1,851,397 2,346,013 2,630,179 2,714,318 2,111,155 11,653,062
2010 15,060,604 9,540,668 6,141,544 3,824,121 1,476,686 36,043,623
2011 2,636,713 3,858,949 3,812,448 3,477,274 2,342,865 16,128,249
2006–11 7,973,682 6,586,729 4,710,291 3,751,799 2,254,066 25,276,566
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across SC/ST quintiles. Thus, in addition to efforts to
scale up and/or consolidate the VAS programme in the
states where VAS coverage is low or erratic, states need
to give particular attention to expanding the coverage of
the programme in sub-district-level units (i.e. blocks and
villages) with higher concentrations of SC/ST children,
keeping in mind that SC children are less likely to bene-
fit from geographical targeting/emphasis and therefore
may require more innovative programming approaches.Table 5 Estimated number of SC/ST children 6–59 months old not
(two doses/child/year) by SC/ST concentration quintile. Vitamin A su
SC/ST children by SC/ST concen
Year Lowest Lower
Not covered 2006 1,258,261 1,315,724
2007 663,490 672,275
2008 370,823 376,910
2009 165,063 97,124
2010 336,459 559,498
2011 116,676 80,731
2006–11 485,129 517,044
Not fully covered 2006 1,460,606 1,674,558
2007 2,090,929 1,566,876
2008 725,217 1,183,445
2009 365,497 391,121
2010 2,224,894 1,725,555
2011 483,371 773,457
2006–11 1,225,086 1,219,169It will also be crucial that the state VAS programmes
be part of an integrated and sustained assault on VAD
that encompasses improved child feeding and increased
vitamin A intakes through the life cycle. Studies have
documented that 42 % of Indian children are not fed
vitamin A-rich foods regularly and that most children do
not even meet 50 % of the recommended vitamin A re-
quirements [22–24, 32, 33]. Importantly, studies have
shown that Indian children who are not fed vitamin A-
rich foods tend to be younger and are less likely to havecovered (at least one dose/child/year) and not fully covered
pplementation (VAS) programme, India 2006–2011
tration quintiles
Middle Higher Highest All
952,295 815,549 1,058,085 5,399,914
672,743 440,884 486,825 2,936,217
167,556 118,151 93,205 1,126,645
49,560 142,164 114,886 568,797
207,916 171,496 93,491 1,368,860
256,379 289,125 428,595 1,171,506
384,408 329,562 379,181 2,095,323
1,387,554 1,364,632 1,694,366 7,581,716
1,453,231 1,142,536 1,571,443 7,825,015
1,026,282 1,259,377 1,269,016 5,463,337
581,677 890,537 1,242,207 3,471,039
1,471,009 921,790 870,186 7,213,434
896,030 1,070,832 1,397,436 4,621,126
1,135,964 1,108,284 1,340,776 6,029,278
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months [34]. This situation underscores: (1) the importance
of breast milk as a major source of preformed retinol for
children in the first 2 years of life; (2) the importance of
vitamin A-rich complementary foods for children 6–
23 months old; and (3) the need to universalize the cover-
age of the VAS programme to enhance children’s vitamin A
intake, particularly among the most vulnerable children:
the youngest and the socially excluded.
Conclusions
Indian states have achieved significant progress in
expanding the coverage of the VAS programme. How-
ever, a large proportion of children are not benefitting
from this child survival intervention, particularly among
SC/ST children. These children are potentially among
the most vulnerable to VAD and its consequences.
India’s national VAS programme needs to be strength-
ened in sub-district-level units (i.e. blocks and villages)
with higher concentrations of SC/ST children, with
particular emphasis on SC children. To accelerate pro-
gress in equitable programme coverage, it will be import-
ant to strengthen monitoring and reporting mechanisms
so that state-level programme planners and managers
have access to real-time and accurate information on
programme performance by village, block, and district.
In addition, as India approaches the 2015 deadline to
achieve the Millennium Development Goals (MDG) tar-
gets for child survival, it will be important to reassess
the prevalence of clinical and sub-clinical VAD in pre-
school age children (with appropriate geographic and
socio-economic data disaggregation). This will address
recent concerns about the extent and severity of VAD in
India and the relevance of the national VAS programme
[35, 36] and will provide the evidence base to design In-
dia’s way forward post 2015.
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